ZDA
Zweig-DiMenna Associates’s BioMarin Pharmaceuticals BMRN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q2 | – | Sell |
-160,198
| Closed | -$13.2M | – | 153 |
|
2016
Q1 | $13.2M | Buy |
160,198
+70,198
| +78% | +$5.79M | 1.17% | 30 |
|
2015
Q4 | $9.43M | Sell |
90,000
-206,065
| -70% | -$21.6M | 0.47% | 72 |
|
2015
Q3 | $31.2M | Buy |
296,065
+243,565
| +464% | +$25.7M | 1.35% | 16 |
|
2015
Q2 | $7.18M | Sell |
52,500
-67,000
| -56% | -$9.16M | 0.4% | 69 |
|
2015
Q1 | $14.9M | Sell |
119,500
-115,587
| -49% | -$14.4M | 0.62% | 61 |
|
2014
Q4 | $21.3M | Buy |
235,087
+178,349
| +314% | +$16.1M | 0.91% | 34 |
|
2014
Q3 | $4.09M | Sell |
56,738
-87,937
| -61% | -$6.35M | 0.18% | 111 |
|
2014
Q2 | $9M | Buy |
144,675
+15,000
| +12% | +$933K | 0.41% | 74 |
|
2014
Q1 | $8.85M | Sell |
129,675
-476,174
| -79% | -$32.5M | 0.52% | 66 |
|
2013
Q4 | $42.6M | Buy |
605,849
+36,245
| +6% | +$2.55M | 1.56% | 11 |
|
2013
Q3 | $41.1M | Buy |
569,604
+113,912
| +25% | +$8.22M | 1.67% | 7 |
|
2013
Q2 | $25.4M | Buy |
+455,692
| New | +$25.4M | 1.03% | 19 |
|